Skip to content

Vericel VCEL Business Segments — SG&A

Similar metrics at other companies

ALN
ALNYSingle Reportable Segment — SG&A
$347.92M+7.6%
Agios Pharmaceuticals logo
AGIOReportable Segment — SG&A
$51.55M+12.4%
MiMedx Group logo
MDXGReportable Segment — SG&A
$59.78M-6.8%
Aquestive Therapeutics, Inc. logo
AQSTReportable Segment — SG&A
$10.98M-42.4%
Zevra Therapeutics, Inc. logo
ZVRAReportable Segment — SG&A
$14.35M+19.8%
Indivior Pharmaceuticals, Inc.
 logo
INDVReportable Segment — SG&A
$124M-6.8%

Other financials

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
Operating cash flow$16.2M+97.1%
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation

See full
Market cap$2.39B+16.3%
Enterprise value$2.35B+13.6%
P/E98.5×-190×
P/S7.8×-0.4×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Vericel’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's business segments — sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's business segments — SG&A?
Vericel (VCEL) reported business segments — SG&A of $48.48M in Q2 2026.
What does business segments — SG&A mean?
This metric aggregates all selling, general, and administrative expenses for the company's single reportable segment, representing the total non-production operating costs. It serves as a comprehensive measure of the company's overhead and commercial investment required to maintain and grow its business operations. Investors use this to assess the company's operating leverage and overall cost management discipline.